Fig. 2.
Percent injected decay-corrected activity per gram (%IA/g) in various organs of mice at 1, 3, 10 and 22 h following i.v.-injection with 211At-farletuzumab, 211At-MX35, and 125I-farletuzumab.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.